openPR Logo
Press release

Flu Vaccine (Influenza Vaccine) Market Key Player Analysis By - CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson

09-27-2018 12:24 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Report Hive Research

Flu Vaccine (Influenza Vaccine) Consumption

Flu Vaccine (Influenza Vaccine) Consumption

Global Flu Vaccine (Influenza Vaccine) Market 2018 peaks the detailed analysis of industry share, growth factors, development trends, size, majors manufacturers and 2025 forecast. The report also analyze innovative business strategies, value added factors and business opportunities. The Influenza vaccines report introduces market competition situation among the vendors and company profile, revenue, product & services, latest developments and business strategies.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccine (Influenza Vaccine) market by product type, application, key manufacturers and key regions.

Request for the Sample Copy: https://www.reporthive.com/enquiry.php?id=1611947&req_type=smpl

The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.

Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.

The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Over the next five years, Flu Vaccine (Influenza Vaccine) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

The key players covered in this report:

• CSL
• GSK
• Sanofi Pasteur
• Mylan
• AstraZeneca
• Pfizer
• Johnson & Johnson

Segmentation by product type:

• Whole Virus Vaccines
• Split Virus Vaccines
• Subunit Vaccines
• Live Attenuated Virus Vaccines

Segmentation by application:

• For Children (6 months to 3 years)
• For Adults and Children over 3 years

Click For Buy Full Report: https://www.reporthive.com/enquiry.php?id=1611947&req_type=purch

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia…And More

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. rket.

Table of Contents

2018-2023 Global Flu Vaccine (Influenza Vaccine) Consumption Market Report

1 Scope of the Report

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview
2.1.1 Global Flu Vaccine (Influenza Vaccine) Consumption 2013-2023
2.1.2 Flu Vaccine (Influenza Vaccine) Consumption CAGR by Region
2.2 Flu Vaccine (Influenza Vaccine) Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.2.4 Live Attenuated Virus Vaccines
2.3 Flu Vaccine (Influenza Vaccine) Consumption by Type
2.3.1 Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
2.3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Type (2013-2018)
2.4 Flu Vaccine (Influenza Vaccine) Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Flu Vaccine (Influenza Vaccine) Consumption by Application
2.5.1 Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
2.5.2 Global Flu Vaccine (Influenza Vaccine) Value and Market Share by Application (2013-2018)
2.5.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Application (2013-2018)…And many more

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States

Contact Us
sales@reporthive.com
http://www.reporthive.com
Phone Number: +1-312 604 7084

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Flu Vaccine (Influenza Vaccine) Market Key Player Analysis By - CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson here

News-ID: 1266843 • Views:

More Releases from Report Hive Research

Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
The global Oryzenin market is expected to reach an estimated USD 561.1 Million by 2030 with a CAGR of 14.2% from 2022 to 2030. The Global Oryzenin market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Oryzenin market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth 2022 | BASF, Dow, Trinseo(Styron)
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth …
The global Polymer Emulsions market was estimated at USD 27.3 billion in 2021 and is projected to expand at a CAGR of 7.5% from 2022 to 2030. The Report Hive Research has added a new statistical market report to its repository titled as, Polymer Emulsions Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | Bayer CropScience, Lier Chemical, Zhejiang YongNong
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | …
The global Glufosinate market is expected to reach an estimated USD 4.12 billion by 2030 with a CAGR of 8.68% from 2022 to 2030. The Glufosinate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, Asahi Kasei
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, …
The global Glass Filled Nylon market is projected to register an average CAGR of 5.6% during the forecast period 2022-2030. The Global Glass Filled Nylon market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Glass Filled Nylon market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion